KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $14.00 $16.17 Thursday, 25th Apr 2024 DCPH stock ended at $14.18. This is 3.01% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.18% from a day low at $14.00 to a day high of $14.73.
90 days $13.86 $17.73
52 weeks $9.90 $17.73

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Apr 25, 2024 $14.43 $14.73 $14.00 $14.18 438 038
Apr 24, 2024 $14.70 $14.84 $14.57 $14.62 313 550
Apr 23, 2024 $14.57 $15.19 $14.56 $14.67 414 272
Apr 22, 2024 $14.79 $15.13 $14.58 $14.58 377 421
Apr 19, 2024 $14.17 $14.69 $14.05 $14.67 373 106
Apr 18, 2024 $14.67 $14.91 $14.19 $14.23 743 106
Apr 17, 2024 $14.97 $15.00 $14.66 $14.72 278 082
Apr 16, 2024 $14.76 $15.00 $14.65 $14.84 236 227
Apr 15, 2024 $15.07 $15.13 $14.52 $14.90 489 968
Apr 12, 2024 $15.46 $15.51 $14.87 $15.05 283 514
Apr 11, 2024 $15.81 $15.81 $15.24 $15.52 227 957
Apr 10, 2024 $15.11 $15.71 $14.89 $15.61 518 424
Apr 09, 2024 $14.94 $15.69 $14.94 $15.64 352 737
Apr 08, 2024 $15.42 $15.56 $14.71 $15.01 219 665
Apr 05, 2024 $15.03 $15.57 $14.93 $15.34 296 087
Apr 04, 2024 $15.24 $15.61 $15.09 $15.14 356 562
Apr 03, 2024 $15.08 $15.39 $15.01 $15.29 412 133
Apr 02, 2024 $15.49 $15.64 $14.99 $15.19 384 774
Apr 01, 2024 $15.62 $16.02 $15.43 $15.76 811 230
Mar 28, 2024 $15.37 $16.17 $15.25 $15.73 763 901
Mar 27, 2024 $15.03 $15.20 $14.74 $15.18 288 073
Mar 26, 2024 $15.46 $15.50 $14.79 $14.82 280 999
Mar 25, 2024 $15.34 $15.61 $15.25 $15.30 296 946
Mar 22, 2024 $15.55 $15.63 $15.23 $15.23 236 670
Mar 21, 2024 $15.82 $16.09 $15.48 $15.50 310 908
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT